La lecture en ligne est gratuite
Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres
Télécharger Lire

Elsevier and Russia's Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding

3 pages
Elsevier and Russia's Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding PR Newswire MOSCOW, June 18, 2012 MOSCOW, June 18, 2012 /PRNewswire/ -- Agreement will add to Russia's focus on R&D and its involvement in the international ecosystem of excellence in science and innovation Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today it has reached an agreement with Russia's Skolkovo Foundation, providing access to SciVerse Scopus and SciVal Funding. Skolkovo aims to strengthen the links between Russian and international science, technology, education, entrepreneurship and investment communities. The Skolkovo Foundation manages direct investments in the Skolkovo Innovation Center, Russia's hub of intellectual capital, a city of high tech industries stimulating the development of break-through projects and technologies. The development of the Skolkovo Innovation Center was initiated in 2010 after President Medvedev announced his commitment to Russia's investments in R&D. It has since attracted leading global technology companies such as Microsoft, IBM, Boeing and Ericsson, integrating Russia's R&D program into the international innovation environment. Skolkovo Innovation Center is also home to a major overarching innovation- technology university with direct involvement of Massachusetts Institute of Technology and Russia's leading technology universities.
Voir plus Voir moins
Elsevier and Russia's Skolkovo Foundation
Sign Access Agreement to SciVerse Scopus
and SciVal Funding
PR Newswire
MOSCOW, June 18, 2012
MOSCOW
,
June 18, 2012
/PRNewswire/ --
Agreement will add to Russia's focus on R&D and its involvement in the
international ecosystem of excellence in science and innovation
Elsevier, a world-leading provider of scientific, technical and medical
information products and services, announced today it has reached an
agreement with
Russia's
Skolkovo Foundation, providing access to SciVerse
Scopus and SciVal Funding. Skolkovo aims to strengthen the links between
Russian and international science, technology, education, entrepreneurship and
investment communities.
The Skolkovo Foundation manages direct investments in the Skolkovo
Innovation Center,
Russia's
hub of intellectual capital, a city of high tech
industries stimulating the development of break-through projects and
technologies. The development of the Skolkovo Innovation Center was initiated
in 2010 after President Medvedev announced his commitment to
Russia's
investments in R&D. It has since attracted leading global technology companies
such as Microsoft, IBM, Boeing and Ericsson, integrating
Russia's
R&D program
into the international innovation environment.
Skolkovo Innovation Center is also home to a major overarching innovation-
technology university with direct involvement of Massachusetts Institute of
Technology and
Russia's
leading technology universities. Providing this
university with secured access to SciVerse Scopus and SciVal Funding will
further support Skolkovo's core mission: to foster
Russia's
technological
innovations and bundle research activities to address critical issues at a
national as well as global level.
Alexander Lupachev, Investment Director at the Skolkovo Foundation, said of
the agreement, "At Skolkovo we aim to build a wired work environment,
stimulating innovations in all fields of technology. For us it is important that both
young university graduates as well as world-known scientists from any country
will consider Skolkovo as an attractive place to pursue their scientific careers.
Providing secured access to Elsevier's SciVerse Scopus and SciVal Funding
enables us to give these researchers a unique opportunity to exploit the
benefits of the digital economy and science in terms of expertise, collaboration,
partnerships, virtualization, and resource sharing."
Igor Osipov, PhD, Elsevier Regional Director for
Russia
and
Belarus
added, "We
are well aware that
Russia
has many talented scientists working on cutting-
edge research. We believe that our research and funding tools will help the
Skolkovo Foundation enhance the effectiveness of
Russia's
research and
development cycle from research to commercialization by building an excellent
platform for closer international collaboration. This agreement will serve the
strategic purpose of Skolkovo to attract and retain the best talent by offering
cutting-edge capabilities and information to pursue on-site innovative research
with the fast developing knowledge economy."
About Skolkovo Foundation
The Skolkovo Foundation has the mandate from the Russian Government to
help accelerate the transformation of
Russia
from a resource-intensive to an
innovation-based economy through strategic partnerships with leading
scientists and corporations (currently numbering over 330 companies and start-
ups.) The Foundation aims to strengthen the links between Russian and
international science, technology, education, entrepreneurship and investment
communities. To achieve this objective it is overseeing the creation of the
Skolkovo Innovation Centre composed of five R&D clusters, a Technopark, the
Skolkovo Institute of Technology (a new graduate research University
established in collaboration with the Massachusetts Institute of Technology) and
Skolkovo city, located near
Moscow
. Together these entities will establish a
vibrant eco-system of technology innovation and entrepreneurship.
The
Foundation is a non-profit organization founded in May of 2010 by the Russian
Government with a grant of
USD 5 billion
.
About SciVerse Scopus
Covering the world's research literature, SciVerse Scopus is the largest abstract
and citation database of peer-reviewed literature and quality Web sources with
smart tools to track analyze and visualize research. SciVerse Scopus was
designed and developed with over 500 users and librarians internationally. Its
unique database contains abstracts and references from nearly19,500 peer-
reviewed journals from more than 5,000 publishers worldwide, ensuring broad
interdisciplinary coverage. In addition, SciVerse Scopus not only offers users
citation information about the articles covered, but also directly integrates Web
and patent searches. Direct links to full-text articles, library resources and other
applications like reference management software, make SciVerse Scopus
quicker, easier and more comprehensive to use than any other literature
research tool.
About the Elsevier SciVal Suite
Elsevier's SciVal® suite of services supports academic and government
leadership in evaluating, establishing and executing research strategies that
optimize the performance of existing assets and maximize investments to
enhance near and long-term productivity. SciVal tools leverage Scopus® data,
Elsevier's trusted source of bibliometric data, to offer innovative yet
authoritative solutions. Current suite offerings include: SciVal Spotlight, a
strategic tool that generates unique institutional and country maps of existing
and emerging research strengths based on an interdisciplinary perspective of
current performance; SciVal Funding, an online solution that provides targeted
recommendations on grants to pursue based on pre-populated research
profiles and historical awards; SciVal Strata, a web-based research
performance tool that offers users the flexibility to construct relevant
contextual data to evaluate research teams or individual researchers, using a
range of indicators based on Scopus data; SciVal Experts, a semantic
technology-based application that enables researchers to identify and locate
sources of expertise at an individual or departmental level within and across
institutions.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including
The Lancet
and
Cell
, and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby's
Nursing Suite, which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai's Pinpoint Review, which help
research and health care institutions deliver better outcomes more cost-
effectively.
A global business headquartered in
Amsterdam
, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC, a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier PLC
and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact
Galina Yakshonak
Elsevier,
Russia
+7-985-72-779-67
g.yakshonak@elsevier.com